Container for pharmaceutical substance to be administered nasally

- Glaxo Group Limited
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a perspective view of a container for pharmaceutical substance to be administered nasally, as viewed from the front, showing my new design;

FIG. 2 is a perspective view thereof, as shown from the rear;

FIG. 3 is a right side elevational view thereof, the left side elevational view being a mirror image thereof;

FIG. 4 is a front elevational view thereof;

FIG. 5 is a rear elevational view thereof; and,

FIG. 6 is a top plan view thereof.

Claims

The ornamental design for container for pharmaceutical substance to be administered nasally, as shown and described.

Referenced Cited
U.S. Patent Documents
3342379 September 1967 Foley
D345630 March 29, 1994 Chevassus
5632420 May 27, 1997 Lohrman et al.
D392890 March 31, 1998 Zaksenberg
D397037 August 18, 1998 Negre
5996850 December 7, 1999 Morali et al.
D444227 June 26, 2001 Hennemann et al.
Foreign Patent Documents
813302 June 1991 JP
831531 March 1992 JP
869158 May 1993 JP
952618 January 1999 JP
Patent History
Patent number: D468423
Type: Grant
Filed: Jun 14, 2000
Date of Patent: Jan 7, 2003
Assignee: Glaxo Group Limited (Middlesex)
Inventor: Bruce Renfrew (Leicester)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Darby & Darby
Application Number: 29/124,933
Classifications
Current U.S. Class: Resilient (e.g., Squeeze Bulb, Bellows, Etc.) (9) (D24/115)
International Classification: 2402;